Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic dystrophy type 1, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular diseaseRecruitingNot stated2026-06-10NCT03981575

12 results · Page 1 of 1

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centro Clinico NeMOMilanItaly4
Friedrich Baur Institute, Ludwig-Maximilians-Universität MünchenMünchenGermany1
Houston Methodist Neurological InstituteHoustonUnited States18
Kansas University Medical CenterKansas CityUnited States25
Ohio State UniversityColumbusUnited States169
Radboud University Medical CenterNijmegenNetherlands40
St. George's, University of LondonLondonUnited Kingdom1
University College LondonLondonUnited Kingdom14
University of AucklandAucklandNew Zealand4
University of California, Los AngelesLos AngelesUnited States142
University of California, San DiegoLa JollaUnited States1
University of Colorado - DenverDenverUnited States3
University of FloridaGainesvilleUnited States79
University of IowaIowa CityUnited States284
University of RochesterRochesterUnited States360
Université de SherbrookeQuébecCanada1
Virginia Commonwealth UniversityRichmondUnited States156